DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 1.57% to $10.06 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.63% to 24,836.60 and the Dow Jones Industrial Average falling 0.16% to 49,230.71.
This was the stock's second consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 51.07% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock underperformed when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 2.99% to $6.89, Fortress Biotech Inc. (FBIO) rose 4.48% to $2.33, and Viking Therapeutics Inc. (VKTX) fell 0.15% to $32.75.
Trading volume (242,940) eclipsed its 50-day average volume of 219,266.
Data source: Dow Jones Market Data, FactSet. Data compiled April 24, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 24, 2026 17:21 ET (21:21 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments